Testing effectiveness (Phase 2)Ended earlyNCT00379197
What this trial is testing
Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer
Who this might be right for
Breast Cancer
Masonic Cancer Center, University of Minnesota 13
Showing 20 of 0 results